It wasnt all bad news, with an extremely strong launch for the Wegovy pill, and a reminder of strong clinical progress in the next-generation pipeline at the tail-end of 2025. In London, Britains second-biggest drugmaker, GSK, said sales growth would slow to between 3% and 5% this year, from 7% growth to 32.7bn last year
SGLT2-i reduces both systolic blood pressure (SBP) and diastolic blood pressure (DBP) across multiple trials and meta-analyses with reductions up to 8.6/4.3 mmHg, depending on the agent, dose and population studied
On April 1, 2026, the FDA issued a significant policy clarification targeting the most common remaining workaround: compounders and telehealth providers had been adding a secondary ingredient most commonly vitamin B12 to their semaglutide formulations and marketing them as distinct, patient-specific products not subject to the "essentially a copy" prohibition
However, a doctoraEURtms advice is needed if you wish to know regarding the dosage.PACKING: 14 Sets/Box (14 Vials + 28 Ampoules) People Also Viewed